EPCAM and prostate cancer: Adoptive transfer of peripheral blood lymphocytes (PBL) transduced with an EpCAM-specific CAR prevented metastasis of prostate cancer PC3 cells and significantly reduced tumor growth of PC3M cells in nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice [104].